What is included in a typical monitoring plan after starting osteoporosis treatment?

• A. Weekly imaging
• B. No clinical evaluation
• C. Only initial DEXA
• D. Periodic clinical evaluation, repeat DEXA every 1-2 years, monitor labs as indicated, assess adherence and adverse effects

Answer: (D)

Monitoring after starting osteoporosis therapy focuses on tracking response, staying on therapy, and catching side effects early. A solid plan includes periodic clinical evaluation to assess pain, functional status, falls risk, and any new fractures or adverse symptoms, which helps tailor ongoing care and supports adherence. It also calls for repeat bone density testing with DEXA every 1–2 years to evaluate whether bone density is improving or stabilizing in the face of treatment, since changes in density take time but guide long-term strategy. Lab monitoring is done as indicated—checking calcium, vitamin D, phosphorus, and kidney function as appropriate—to ensure metabolic support for the treatment and to catch issues like hypocalcemia, especially with certain agents. Finally, assessing adherence and potential adverse effects is crucial, so you can address barriers, adjust therapy if needed, and manage risks such as gastrointestinal tolerance with oral meds or rare but serious effects like osteonecrosis of the jaw or hypocalcemia. This combination provides a comprehensive, ongoing way to manage osteoporosis beyond the initial assessment, rather than relying on a single test or no follow-up.